600222.SS
Henan Taloph Pharmaceutical Stock Co.,Ltd [600222.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
600222.SS Stock Summary
Top 10 Correlated Stocks
600222.SS
In the News
600222.SS Financial details
Company Rating
-
Market Cap
3.17B
Income
43.56M
Revenue
2.07B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.35K
Optionable
No
Shortable
Yes
Earnings
26 Apr 2024
P/E
-95.67
Forward P/E
-
PEG
5.93
P/S
1.56
P/B
2.27
P/C
-
P/FCF
-40.38
Quick Ratio
0.79
Current Ratio
1.07
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.08
EPS next Y
-
EPS next Q
-
EPS this Y
-159.54%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-0.63%
Revenue last 5Y
9.45%
Revenue Q/Q
38.86%
EPS Q/Q
187.21%
-
-
-
-
SMA20
-
SMA50
-12.5%
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-1%
ROE
-2%
ROC
-0.03%
Gross Margin
26%
Oper. Margin
-2%
Profit Margin
-2%
Payout
-155%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.75-8.08
52W High
-16.5%
52W Low
+122.67%
RSI
48
Rel Volume
0.64
Avg Volume
16.82M
Volume
10.78M
Perf Week
-1.91%
Perf Month
-1.04%
Perf Quarter
0.15%
Perf Half Y
-4.57%
-
-
-
-
Beta
0.616
-
-
Volatility
0.06%, 0.13%
Prev Close
0%
Price
6.68
Change
-0.45%
Company Profile
- Volume Average 16.82M
- Market Capitalization 3.17B
- Employee 2.35K
- CEO Mr. Jianchao Luo
- Headquarters Zhengzhou,CN
- IPO Date 1999-11-05
-
Website
https://www.taloph.com 
Henan Taloph Pharmaceutical Stock Co., Ltd. researches, produces, and sells Chinese and western medicines in China. It primarily offers its products in the forms of oral liquids, tablets, capsules, fluids, and other forms. The company's principal products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, pazufloxacin mesylate sodium chloride injections, and various infusion products. It serves hospitals, pharmacies, and patients. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co., Ltd. is based in Zhengzhou, China.
